TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T35734	Soluble epoxide hydrolase	B1FUX5	Methyl (5-methyl-4-phenyl-1,3-thiazol-2-yl)carbamate	Investigative	1220478	C12H12N2O2S	248.3	CC1=C(N=C(S1)NC(=O)OC)C2=CC=CC=C2	IC50 = 379000 nM	Non binder
T35734	Soluble epoxide hydrolase	B3QRS5	1-Cyclohexyl-3-(3-hydroxypropyl)urea	Investigative	2061174	C10H20N2O2	200.28	C1CCC(CC1)NC(=O)NCCCO	IC50 > 500000 nM	Non binder
T35734	Soluble epoxide hydrolase	B43OBA	1-[3-(Trifluoromethyl)pyridin-2-yl]piperazine	Investigative	2777786	C10H12F3N3	231.22	C1CN(CCN1)C2=C(C=CC=N2)C(F)(F)F	IC50 = 1200000 nM	Non binder
T35734	Soluble epoxide hydrolase	BI8F3S	1-Cyclohexyl-3-(5-hydroxy-pentyl)-urea	Investigative	44307465	C12H24N2O2	228.33	C1CCC(CC1)NC(=O)NCCCCCO	IC50 = 253000 nM	Non binder
T35734	Soluble epoxide hydrolase	BKR4W2	Fuberidazole	Investigative	19756	C11H8N2O	184.19	C1=CC=C2C(=C1)NC(=N2)C3=CC=CO3	IC50 = 207000 nM	Non binder
T35734	Soluble epoxide hydrolase	BP2FX5	N-Methyl-N-(3-pyridin-3-ylbenzyl)amine	Investigative	7060576	C13H14N2	198.26	CNCC1=CC(=CC=C1)C2=CN=CC=C2	IC50 = 2200000 nM	Non binder
T35734	Soluble epoxide hydrolase	BS4B3K	N-[(1-Methyl-1H-pyrazol-3-yl)methyl]-2-phenylethanamine	Investigative	7017351	C13H17N3	215.29	CN1C=CC(=N1)CNCCC2=CC=CC=C2	IC50 = 800000 nM	Non binder
T35734	Soluble epoxide hydrolase	BT0QC5	Tert-Butyl (1,2,3,4-tetrahydroquinolin-3-yl)carbamate	Investigative	4460996	C14H20N2O2	248.32	CC(C)(C)OC(=O)NC1CC2=CC=CC=C2NC1	IC50 = 580000 nM	Non binder
T35734	Soluble epoxide hydrolase	BZC50J	3-[(Cyclohexylcarbamoyl)amino]propanoic acid	Investigative	11020253	C10H18N2O3	214.26	C1CCC(CC1)NC(=O)NCCC(=O)O	IC50 = 358000 nM	Non binder